Walgreen's WHP pilot study encourages testing for H. pylori in high-risk patients.
Executive Summary
WALGREEN's WHP H. PYLORI EDUCATION PILOT STUDY will assess cost-effectiveness of Walgreen's pharmacy benefit management subsidiary WHP Health Initiatives' approach to encourage testing for treatment of ulcers caused by Helicobacter pylori, WHP Managed Care Pharmacy Resident Mark Matusik told the Academy of Managed Care annual meeting in New Orleans May 9. WHP Health Initiatives surveyed 5,062 patients chosen from Walgreen's pharmacy database on the basis of long-term use of acid-lowering drugs. Forty-five percent of patients responded.